Literature DB >> 25367179

Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis.

Irshad Shaikh1, Alan Askari, Suzana Ourû, Janindra Warusavitarne, Thanos Athanasiou, Omar Faiz.   

Abstract

BACKGROUND: Low rectal cancer is conventionally managed with neoadjuvant chemoradiotherapy (CRT) followed by radical surgery (RS). In patients who refuse a stoma or are unfit for RS, an alternative approach may be the use of pre-op CRT and local excision (LE) where tumours are responsive. The aim of this systematic review is to determine whether differences exist in local recurrence (LR), overall survival (OS) and disease-free (DFS) survival between patients treated with CRT + LE and CRT + RS.
METHODS: A literature search was performed using MEDLINE/PubMed/Ovid databases and Google Scholar between 1946 and 2013. Studies comparing outcome following LE and RS post-CRT were included. A pooled analysis was carried out using the Mantel-Haenszel statistical (random effects) model to identify differences in LR, OS and DFS between CRT + LE and CRT + RS.
RESULTS: Eight studies were suitable for pooled analyses of LR whereas five and four studies were analysed for OS and DFS, respectively. When RS was used as the reference group, LR rate was higher in the LE group. However, this was non-significant (odds ratio (OR) 1.29, confidence interval (CI) 0.72-2.31, p = 0.40). Similarly, no difference was observed in 10-year OS (OR 0.96, CI 0.38-2.43, p = 0.93) or 5-year DFS (OR 1.04, CI 0.61-1.76, p = 0.89). There was evidence of publication bias in studies used for DFS. Subgroup analysis of above outcomes in T3/any N stage cancers showed no difference in LE versus RS.
CONCLUSION: In the current evidence synthesis, there was no statistical difference in the LR, OS and DFS rates observed between patients treated with LE and RS for rectal cancer post-CRT. LE post-CRT may represent a viable alternative to RS for some patients wishing to avoid RS. However, further randomised studies are required to confirm these results.

Entities:  

Mesh:

Year:  2014        PMID: 25367179     DOI: 10.1007/s00384-014-2045-1

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  44 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection.

Authors:  Tae Hyun Kim; Seung-Yong Jeong; Dong Hyun Choi; Dae Yong Kim; Kyung Hae Jung; Sung Ho Moon; Hee Jin Chang; Seok-Byung Lim; Hyo Seong Choi; Jae-Gahb Park
Journal:  Ann Surg Oncol       Date:  2007-12-05       Impact factor: 5.344

3.  Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy.

Authors:  Angelita Habr-Gama; Rodrigo O Perez; Igor Proscurshim; Fábio G Campos; Wladimir Nadalin; Desiderio Kiss; Joaquim Gama-Rodrigues
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

4.  Effects of preoperative chemoradiotherapy on anal sphincter functions and quality of life in rectal cancer patients.

Authors:  Aras Emre Canda; Cem Terzi; Ilknur B Gorken; Ilhan Oztop; Selman Sokmen; Mehmet Fuzun
Journal:  Int J Colorectal Dis       Date:  2009-09-26       Impact factor: 2.571

5.  Improved survival with preoperative radiotherapy in resectable rectal cancer.

Authors:  B Cedermark; M Dahlberg; B Glimelius; L Påhlman; L E Rutqvist; N Wilking
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

6.  High-dose preoperative radiation and full-thickness local excision. A new option for patients with select cancers of the rectum.

Authors:  G Marks; M M Mohiuddin; L Masoni; L Pecchioli
Journal:  Dis Colon Rectum       Date:  1990-09       Impact factor: 4.585

Review 7.  Rectum-conserving surgery in the era of chemoradiotherapy.

Authors:  F M Smith; D Waldron; D C Winter
Journal:  Br J Surg       Date:  2010-12       Impact factor: 6.939

8.  Transanal endoscopic microsurgery for local excision of rectal lesions: is there a learning curve?

Authors:  B Koebrugge; K Bosscha; M F Ernst
Journal:  Dig Surg       Date:  2009-11-13       Impact factor: 2.588

Review 9.  Early rectal cancer: local excision or radical surgery?

Authors:  Alexandre Jin Bok Audi Chang; Caio Sergio Rizkallah Nahas; Sergio E Alonso Araujo; Sergio C Nahas; Carlos F Sparapan Marques; Desiderio Roberto Kiss; Ivan Cecconello
Journal:  J Surg Educ       Date:  2008 Jan-Feb       Impact factor: 2.891

10.  Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.

Authors:  In Ja Park; Y Nancy You; John M Skibber; Miguel A Rodriguez-Bigas; Barry Feig; Sa Nguyen; Chung-Yuan Hu; George J Chang
Journal:  Dis Colon Rectum       Date:  2013-02       Impact factor: 4.585

View more
  13 in total

1.  Current status of local treatment for early rectal cancer in Japan: a questionnaire survey by the 81st Congress of the Japanese Society for Cancer of the Colon and Rectum (JSCCR) in 2014.

Authors:  Hidetoshi Katsuno; Koutarou Maeda; Tsunekazu Hanai; Yoshikazu Koide; Hiroshi Matsuoka; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2015-08-13       Impact factor: 3.402

Review 2.  Transanal endoscopic microsurgery for rectal cancer: T1 and beyond? An evidence-based review.

Authors:  Marco E Allaix; Alberto Arezzo; Mario Morino
Journal:  Surg Endosc       Date:  2016-02-22       Impact factor: 4.584

3.  Interplay between long noncoding RNA ZEB1-AS1 and miR-101/ZEB1 axis regulates proliferation and migration of colorectal cancer cells.

Authors:  Wan-Cheng Xiong; Na Han; Nan Wu; Ke-Lei Zhao; Chen Han; Hui-Xin Wang; Guan-Fang Ping; Peng-Fei Zheng; Hailong Feng; Lei Qin; Peng He
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

Review 4.  Multidisciplinary management of elderly patients with rectal cancer: recommendations from the SICG (Italian Society of Geriatric Surgery), SIFIPAC (Italian Society of Surgical Pathophysiology), SICE (Italian Society of Endoscopic Surgery and new technologies), and the WSES (World Society of Emergency Surgery) International Consensus Project.

Authors:  Mauro Podda; Patricia Sylla; Gianluca Baiocchi; Michel Adamina; Vanni Agnoletti; Ferdinando Agresta; Luca Ansaloni; Alberto Arezzo; Nicola Avenia; Walter Biffl; Antonio Biondi; Simona Bui; Fabio C Campanile; Paolo Carcoforo; Claudia Commisso; Antonio Crucitti; Nicola De'Angelis; Gian Luigi De'Angelis; Massimo De Filippo; Belinda De Simone; Salomone Di Saverio; Giorgio Ercolani; Gustavo P Fraga; Francesco Gabrielli; Federica Gaiani; Mario Guerrieri; Angelo Guttadauro; Yoram Kluger; Ari K Leppaniemi; Andrea Loffredo; Tiziana Meschi; Ernest E Moore; Monica Ortenzi; Francesco Pata; Dario Parini; Adolfo Pisanu; Gilberto Poggioli; Andrea Polistena; Alessandro Puzziello; Fabio Rondelli; Massimo Sartelli; Neil Smart; Michael E Sugrue; Patricia Tejedor; Marco Vacante; Federico Coccolini; Justin Davies; Fausto Catena
Journal:  World J Emerg Surg       Date:  2021-07-02       Impact factor: 5.469

5.  Feasibility of Neoadjuvant FOLFOX Therapy Without Radiotherapy for Baseline Resectable Rectal Cancer.

Authors:  Michihiro Koizumi; Takeshi Yamada; Seiichi Shinji; Yasuyuki Yokoyama; Goro Takahashi; Takuma Iwai; Kohki Takeda; Keisuke Hara; Keiichiro Ohta; Eiji Uchida; Hiroshi Yoshida
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

6.  Adjuvant chemoradiotherapy instead of revision radical resection after local excision for high-risk early rectal cancer.

Authors:  Jae-Uk Jeong; Taek-Keun Nam; Hyeong-Rok Kim; Hyun-Jeong Shim; Yong-Hyub Kim; Mee Sun Yoon; Ju-Young Song; Sung-Ja Ahn; Woong-Ki Chung
Journal:  Radiat Oncol       Date:  2016-09-05       Impact factor: 3.481

7.  Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.

Authors:  B Creavin; E Ryan; S T Martin; A Hanly; P R O'Connell; K Sheahan; D C Winter
Journal:  Br J Cancer       Date:  2016-12-20       Impact factor: 7.640

Review 8.  Controversial issues in radiotherapy for rectal cancer: a systematic review.

Authors:  Jong Hoon Kim
Journal:  Radiat Oncol J       Date:  2017-12-29

Review 9.  Neoadjuvant therapy and subsequent treatment in rectal cancer: balance between oncological and functional outcomes.

Authors:  Qiyuan Qin; Lei Wang
Journal:  J Anus Rectum Colon       Date:  2018-04-26

10.  LncRNA ZEB1-AS1 Regulates Colorectal Cancer Cells by MiR-205/YAP1 Axis.

Authors:  Zhong Jin; Bing Chen
Journal:  Open Med (Wars)       Date:  2020-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.